Tirzepatide for cannabis use disorder
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether a weekly injection called tirzepatide (a drug used for diabetes and weight loss) can help people reduce their cannabis use. If you're interested in cutting down and have a higher body weight, this trial might offer a new approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with cannabis use disorder (moderate or severe)
- You use cannabis at least 4 days a week and want to cut down or stop
- You have a body mass index (BMI) of 22 or higher
- You do not have serious mental health conditions like schizophrenia or bipolar disorder
- You do not have diabetes or a family history of a certain thyroid cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide, a medicine used for type 2 diabetes and weight loss, can help people with severe cannabis use disorder cut down or quit. It may reduce cravings and other symptoms of withdrawal.
This study tests whether tirzepatide, a medicine used for diabetes and weight loss, can help reduce cannabis use in people with moderate to severe cannabis use disorder. If you qualify, you would take the medicine for a period and track your cannabis use.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests a medication called tirzepatide (which can help with weight loss) combined with talking therapy (cognitive-behavioural therapy) to help people reduce or stop drinking alcohol while also losing weight. It may be a good fit if you're overweight and want to change your drinking habits.
This trial tests whether a weekly injection called tirzepatide (a diabetes and weight-loss medication) can help people with obesity and stimulant use disorder reduce stimulant use and lose weight. It aims to see if treating both conditions together improves outcomes.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
Hear when a new Cannabis Use Disorder, Moderate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.